The 2023 European Society of Cardiology (ESC) guidelines for acute and chronic heart failure (HF) include upgraded recommendations for intravenous (IV) iron supplementation, including Ferinject ® ...
ST GALLEN, Switzerland--(BUSINESS WIRE)-- Regulatory News: Vifor Pharma today presented the full results from the AFFIRM-AHF study at the 2020 American Heart Association (AHA) Scientific Sessions ...
ST. GALLEN, Switzerland & BEIJING--(BUSINESS WIRE)-- Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com ...
The usage age for JW Pharmaceutical's high-dose iron injection 'Ferinject (ingredient name: ferric carboxymaltose)' has been expanded from ages 14 and older to ages 1 and older. The company recently ...
Results of a subanalysis from the FAIR-HF (Ferinject(R) Assessment in patients with IRon deficiency and Chronic Heart Failure) study demonstrate that correcting iron deficiency with Ferinject(R) ...
ZURICH, June 26 (Reuters) - Swiss healthcare products supplier and drugmaker Galenica received approval for its iron replacement product Ferinject in Europe, the company said on Tuesday. "The UK ...
Vifor Pharma has published findings from a major study which shows that its intravenous treatment Ferinject significantly prolongs the time until other anaemia treatment is needed. Vifor Pharma has ...
CSL Vifor and Fresenius Kabi announced on Nov. 28. 2022 that China’s National Medical Products Administration (NMPA) has approved Ferinject (ferric carboxymaltose), a preparation for intravenous iron ...
St. Gallen, switzerland – 28 August 2023 – CSL Vifor is pleased to announce that the European Society of Cardiology (ESC) have upgraded recommendations in the ESC ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221127005020/en/ CSL Vifor and Fresenius Kabi today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results